HomeWhat We DoOur PortfolioTestimonialsWho We AreContact Enigma Holdings Group supported Wichtig from 2013-2017, enabling Wichtig Publishing to open Wichtig International Ltd in the UK and expand its network of specialist partners worldwide. They standardised marketing and production procedures and expanded their portfolio increasing revenue by 92%. Wichtig was purchased by SAGE Publications in January 2018 Visit Website

HomeWhat We DoOur PortfolioTestimonialsWho We AreContact Peter George Chairman ‍ ‍ ‍ Peter has over 40 years’ experience in healthcare and life sciences, having qualified in Pathology, with a Masters in both ClinicalBiochemistry and Immunology and an Executive MBA from Kellogg School of Management, Northwestern University Chicago. In 2017 he stepped down from running Clinigen plc to found Enigma Holdings, an investment company that specialises in health, wellbeing, sport, learning, community and social housing, and XPG Ltd an investment company focused on property. Clinigen Group plc is a company hestarted in 2010 as a global specialty pharmaceuticals and pharma servicesbusiness and floated in 2012; by 2016 it had a c.£1bn+ market cap, being one of the most successful floats on the AIM stock market. Prior to Clinigen Peter led the £67m management buy-out of Penn Pharmaceuticals, which was crowned “the PE deal of the year 2007”, where he was also named European Private Equity CEO of the year 2010. Whilst leading Clinigen numerous awards were gained for the company; No.1 Sunday Times Fast Track profit 100 (2011),Bionow Investment deal of the year(2012), M&AAwards IPO of the year & AIM Awards Best Newcomer (2013), European BusinessAwards – Business of TO €26m-€150m (2014) and LSE Top 100 inspiring Britishcompanies (2015). And for Peter personally he was named European Mediscience CEO of the year in 2014 and Entrepreneur of the year at the 2016 AIM Awards. In addition to Enigma Holdings and XPG, Peter currently holds a number of public and private company roles; Chairman of Benchmark Holdings PLC, NED at Osler Diagnostics, advisor at Clinigen Group, Ergomed plc,Gresham House and Oxford Sciences Innovations plc. ‍

HomeWhat We DoOur PortfolioTestimonialsWho We AreContact “Enigma’s investment and support has allowed the management team to speed up the expansion of 59club around the world, continue with its key strategy of employing the best staff and allow the implementation of key IT projects that support that growth.” Simon Wordsworth CEO, 59 Club

HomeWhat We DoOur PortfolioTestimonialsWho We AreContact 59Club are Europe's leading Customer Service Analysts and Training Provider...pioneering Member & Visitor Surveys, Mystery Shopper Audits & Staff Training within the Golf, Leisure, Spa, Events, F&B and Hotel Industries. Visit Website